CIK 0001840439 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Biomea Fusion, Inc.
Sign in to watch- Ticker
- BMEA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 980-9099
- Business address
- 1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Grant or award Chief Financial Officer acquired 4,273 shares (grant or award)
- 4 Open-market sale 10% owner sold 125,000 shares at an average $34.11 ($4,263,915)
- 144 Insider Sale of Securities
- 4 Open-market sale 10% owner sold 25,000 shares at $33.84 ($846,000)
- 4 Open-market sale 10% owner sold 250,000 shares at an average $34.30 ($8,575,030)
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 144 Insider Sale of Securities
- 4 Open-market sale 10% owner sold 200,000 shares at $29.12 ($5,823,760)
- 144 Insider Sale of Securities
- 4/A Open-market sale 10% owner sold 200,000 shares at $31.25 ($6,250,000)
- 4 Open-market sale 10% owner sold 200,000 shares at $31.25 ($6,250,000)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 400,000 shares at $30.00 ($12,000,000)
Page 8 of 15 · 292 filings